论文部分内容阅读
预混胰岛素具有兼顾空腹与餐后血糖控制、注射次数较少的优势,因此在我国临床上应用很广泛,尤其是在基层。然而,随着临床研究证据的积累,预混胰岛素尤其是预混胰岛素类似物的临床应用也需要与时俱进。中华医学会内分泌学分会在2013年曾组织专家编写了《预混胰岛素临床应用共识》,2016年又再次进行了更新。现将《预混胰岛素临床应用专家共识(2016年版)》与大家分享。
Premixed insulin with both fasting and postprandial blood glucose control, the advantages of fewer injections, it is widely used in clinical practice in our country, especially in the grassroots. However, with the accumulation of clinical research evidence, the clinical application of premixed insulin, especially premixed insulin analogues, also needs to keep pace with the times. In 2013, the Chinese Society of Endocrinology Branch of the Chinese Medical Association organized experts to write a consensus on the clinical application of premixed insulin, which was once again updated in 2016. Now “premixed insulin clinical application of expert consensus (2016 version)” to share with you.